Clinical trials
Completed Observational Prostatic Hyperplasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 11 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 17 |
| Boehringer Ingelheim | 11 |
| Boston Scientific Corporation | 4 |
| Seoul National University Hospital | 3 |
| Ain Shams University | 2 |
| Assiut University | 2 |
| Samsung Medical Center | 2 |
| St. Luke's Medical Center, Philippines | 2 |
| University of Florence | 2 |
| ALI KAMAL M. SAMI | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 96 |
| Prostatic Neoplasms | 16 |
| Lower Urinary Tract Symptoms | 11 |
| Erectile Dysfunction | 3 |
| Urinary Retention | 3 |
| Prostatitis | 2 |
| Urinary Bladder Neck Obstruction | 2 |
| Urinary Bladder Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Arteriovenous Malformations | 1 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.